The virtual pre-registration fee for trainee and postdoctoral students is also FREE so that the committee provides them with crucial opportunities to not only learn the cutting-edge knowledge in the field of Oncology but also interact with renowned researchers and peers.
We would like to invite you all to attend the FARO-Varian Webinar this month which will be held on Wednesday, April 27th, 2022.
Latest Info: On the road to the 2022 World Cancer Congress – see who is coming
Preparations for the 2022 World Cancer Congress are well underway, with experts and leaders from 80 different countries having already confirmed their presence.
15th Annual Meeting of the Korean Society of Medical Oncology 2022 International Conference (KSMO 2022)
Abstract Submission Deadline Extended : May 25, 2022 (KST)
Call for Application: Merck Foundation Capacity Advancement Program
Application Deadline: 30th April 2022
15th Congress of Asian Society of Cardiovascular Imaging in HYBRID format on 24-26 June 2022 in Hong Kong SAR, China
Hong Kong College of Radiologists and Hong Kong College of Cardiology will jointly organise the 15th Congress of Asian Society of Cardiovascular Imaging (ASCI 2022 HONG KONG) on 24-26 June 2022 (Friday-Sunday) at Hong Kong Convention and Exhibition Centre in HYBRID format.
Hong Kong College of Radiologists and Hong Kong College of Cardiology will jointly organise the 15th Congress of Asian Society of Cardiovascular Imaging (ASCI 2022 HONG KONG) on 24-26 June 2022 (Friday-Sunday) at Hong Kong Convention and Exhibition Centre in HYBRID format.
Sarawak General Hospital (SGH) has recently been selected as the newest ASCO International Cancer Corps (ICC) site. The ICC is an educational exchange program that engages ASCO member-volunteers to improve the quality of cancer care at medical institutions in low- and middle-income countries.
Date : 17th February 2022 (Thursday)
Time : 2.00 – 4.00 pm
Venue : Zoom Meeting (meeting link will be provided upon registration)
This program is part of CRM’s initiative to instil interest and promote clinical trials among young clinicians and CRM hope that this may translate into a healthy growth of principal investigators in the country.
